Brighton Jones’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Brighton Jones's NVAX Position: Q3 2026 in Review
Brighton Jones sold out of Novavax (NVAX) in Q3 2026, closing a stake of 11,427 shares — an estimated $108K sold.
Brighton Jones first reported a position in NVAX in Q4 2021 and held it in 2 quarters. The position peaked at $214K in Q4 2021. 262 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- Brighton Jones reported no remaining Novavax position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 11,427 Novavax shares in Q3 2026, an estimated $108K.
- Brighton Jones first reported a position in Novavax in Q4 2021 and held it in 2 quarters.
- Brighton Jones's Novavax position peaked at $214K in Q4 2021.
- 262 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.